LeMaitre Vascular, Inc. (LMAT) Stock

LeMaitre Vascular, Inc. is a global leader in the design, marketing, sales, servicing, and support of medical devices and implants used in the treatment of peripheral vascular disease. The company offers a comprehensive portfolio of specialized products essential for vascular interventions worldwide. This includes advanced tools such as angioscopes for visualizing blood vessel lumens, embolectomy catheters for removing blood clots, and occlusion catheters that temporarily halt blood flow.

Additionally, LeMaitre Vascular provides perfusion catheters designed to infuse fluids into the vasculature, and thrombectomy catheters equipped with silicone balloons to eliminate thrombi from the venous system. The company's offerings extend to essential devices like carotid shunts used during carotid endarterectomy surgeries, and radiopaque tape facilitating precise localization of tributaries or lesions under the skin.

Moreover, LeMaitre Vascular manufactures valvulotomes, specialized instruments for disrupting valves in veins to function as arteries, and vascular grafts essential for bypassing or replacing diseased arteries. The company also produces vascular and cardiac patches used for vessel closure after surgical procedures, along with innovative closure systems featuring titanium clips that replace traditional sutures.

Operating through a combination of direct sales teams and a global network of distributors, LeMaitre Vascular markets its extensive product range worldwide. Originally founded as Vascutech, Inc., the company changed its name to LeMaitre Vascular, Inc. in 2001. Established in 1983 and headquartered in Burlington, Massachusetts, LeMaitre Vascular continues to innovate and expand its offerings to advance the treatment of peripheral vascular disease and improve patient outcomes globally.